# Efficacy and Safety of GPR119 Agonist DS-8500a in Japanese Patients with Type 2 Diabetes: a Randomized, Double-Blind, Placebo-Controlled, 12-Week Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-gpr119-agonist-ds-8500a-in-japanese-patients-with-type-2/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yuichiro Yamada,Yasuo Terauchi,Hirotaka Watada,Yasuhiko Nakatsuka,Kazuhito Shiosakai,Takuo Washio,Takashi Taguchi |
| Citations | 31 |
| DOI | 10.1007/s12325-018-0668-2 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s12325-018-0668-2.pdf |
| OpenAlex ID | https://openalex.org/W2791429440 |
| PMID | 29488152 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Kazuhito Shiosakai](https://scholariq.org/researchers/kazuhito-shiosakai/)

## Paper journal

- [Advances in Therapy](https://scholariq.org/journals/advances-in-therapy/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.